2023 Enzymes, Coenzymes and Metabolic Pathways GRC and GRS

2023 酶、辅酶和代谢途径 GRC 和 GRS

基本信息

批准号：
10753274
负责人：
Luiz Sorio De Carvalho
金额：
$ 0.6万
依托单位：
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-07-06 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10753274
关键词：
Academia Area Biochemical Reaction Biological Process Biological Sciences Biology Chemicals Coenzymes Collaborations Communication Communities Development Discipline Disease Drug Targeting Enzymatic Biochemistry Enzymes Enzymes and Coenzymes Ethnic Origin Fostering Future Gender Goals Health Healthcare Human Industry Institution Knowledge Life Malignant Neoplasms Metabolic Metabolic Pathway Metabolism Methodology Methods Molecular Biology Nationalities Nature Oral Organism Outcome Peripheral Play Positioning Attribute Postdoctoral Fellow Process Recording of previous events Research Research Personnel Resort Role Running Schedule Scientist Structure Students Therapeutic Underrepresented Populations Vision Woman biophysical chemistry career design experience improved infectious disease treatment interest meetings method development novel therapeutics peer posters programs recruit success symposium underserved community

项目摘要

Project Summary This proposal seeks partial support for the 2023 Enzymes, Coenzymes, and Metabolic Pathways GRC/GRS. These meetings are scheduled for July 15–16 (GRS) and July 16–21 (GRC) at the Waterville Valley Resort, in Waterville Valley, NH. The “Enzymes” GRC/GRS is the paramount conference for scientists investigating the structure and function of enzymes and their role in metabolism and disease. The long-term goals of this conference are to stimulate communication within the broad research community with interests in the roles of enzymes in life’s essential biological processes. To reach these goals, the GRC has developed a technical program of 36 speakers (28 invited and 8 selected from poster abstracts), and the GRS has assembled a program of 9 speakers (1 invited and 8 chosen from poster abstracts) as well as a Bioscience Careers Panel consisting of ~5 leaders from various backgrounds. These oral presentations will disclose the most recent findings in enzymology, experimental method development, as well as how these are implicated in disease. The GRC Chairs have emphasized that these scholars reflect a diverse and inclusive backgrounds: half of the scheduler speakers are women, and several are from underrepresented groups. We also hope to recruit attendees from a similarly wide expanse of diverse backgrounds. Afternoon poster sessions provide an opportunity for all attendees to share their discoveries with the broader scientific community. Of particular importance is that these poster sessions encourage close interactions among both junior and senior investigators. This proposal has high significance because the “Enzymes” GRC is a pivotal conference for researchers investigating the mechanisms of biochemical reactions and provides a central venue for the exchange of knowledge in this essential health-related field. From a healthcare perspective, this proposal is highly significant due to its focus on the development of new enzyme-targeted drugs. A major outcome of this proposal will be the continued elucidation of how enzymes, co-enzymes, and metabolic pathways contribute to the development of new therapeutics, especially for the treatment of infectious diseases and cancer.

项目概要该提案寻求对 2023 年酶、辅酶和代谢途径的部分支持 GRC/GRS 会议定于 7 月 15 日至 16 日（GRS）和 7 月 16 日至 21 日（GRC）在位于新罕布什尔州沃特维尔谷的沃特维尔谷度假村“酶”GRC/GRS 是最重要的。研究酶的结构和功能及其在新陈代谢中的作用的科学家会议本次会议的长期目标是促进广泛的交流。对酶在生命基本生物过程中的作用感兴趣的研究团体。为了实现这些目标，GRC 制定了由 36 名演讲者组成的技术计划（28 名受邀演讲者和 8 名受邀演讲者）选自海报摘要），GRS 已安排了 9 名演讲者（1 名受邀者和 8 名从海报摘要中选出）以及生物科学职业小组，由约 5 位领导者组成这些口头报告将揭示酶学的最新发现，实验方法的开发，以及这些方法与疾病的关系。都强调这些学者体现了多元化和包容性的背景：一半的调度者演讲者是女性，其中一些来自代表性不足的群体。我们还希望招募与会者。来自同样广泛的不同背景的下午海报会议提供了一个机会。让所有与会者与更广泛的科学界分享他们的发现。重要的是，这些海报会议鼓励初级和高级之间的密切互动这项提案具有很高的意义，因为“酶”GRC 是一次关键会议。为研究生化反应机制的研究人员提供一个中心场所从医疗保健的角度来看，这是为了交流这一重要的健康相关领域的知识。该提案非常重要，因为其重点是开发新的酶靶向药物 A。该提案的主要成果将是继续阐明酶、辅酶和代谢途径有助于新疗法的开发，特别是对于治疗传染病和癌症。